Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration

• Status: Completed
• Trial end date: 2018-06-14
• Target enrollment: 0
• Participant gender: Female

Summary

This is a randomized controlled double-blind placebo-controlled trial evaluating the impact of gabapentin given preoperatively on perioperative pain scores for women receiving uterine aspiration between 6 and 14+6 weeks gestation. This study will be a trial included in a prospective meta-analysis evaluating the use of gabapentin on perioperative pain in the abortion setting.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Duke University
• Treatments: Gabapentin; gamma-Aminobutyric Acid

Criteria

Inclusion Criteria:

• Women >=18 years-old

• Presenting for a surgical abortion

• No contraindication to outpatient abortion

• No contraindication to gabapentin

• Fluency in English and able to provide informed consent

Exclusion Criteria:

• Allergy, sensitivity or contraindication to gabapentin

• Severe renal disease

• Currently using gabapentin or pregalabin